據報內地第二批藥品集中帶量採購試點明日起落地實施
據《第一財經》報道,首批藥品集中帶量採購試點實施一年來完成了約定採購量的近兩倍。目前,首批「4+7」已滿一年的試點地區面臨續約問題,第二批帶量採購試點將從4月起陸續落地實施。
據悉,國家醫保局近日已經向各省醫保局下發文件,表示當前新冠肺炎疫情防控形勢持續向好,生產生活秩序加快恢復,各地醫保部門要在打贏疫情防控阻擊戰的同時,積極化解疫情影響,著眼於4月份全面扎實做好第二批集採結果落地實施工作。(ta/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.